Cargando…

Use of flash glucose-sensing technology in patients with type 2 diabetes treated with liraglutide combined with CSII: a pilot study

Glycemic variability (GV) may be linked to the development of diabetic complications by inducing inflammation, oxidative stress, and endothelial dysfunction. Flash glucose monitoring (FGM) provides a novel method of continuously monitoring interstitial glucose levels for up to 14 days. This study ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Ming-yan, Li, Li-qin, Ma, Jian-xia, Xue, Peng, Li, Yu-kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Divulgação Científica 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915907/ https://www.ncbi.nlm.nih.gov/pubmed/31859911 http://dx.doi.org/10.1590/1414-431X20198652

Ejemplares similares

Sensor-augmented CSII therapy with predictive low-glucose suspend following total pancreatectomy
por: Scott, E S, et al.
Publicado: (2017)

To Assess Liraglutide’s Therapeutic Effect in Patients with Type 2 Diabetes Mellitus Using Flash Glucose Monitoring System
por: Yin, Jianhong, et al.
Publicado: (2021)

Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes
por: Haak, Thomas, et al.
Publicado: (2017)

Glucose Variability and β- Cell Response by GLP-1 Analogue added-on CSII for Patients with Poorly Controlled Type 2 Diabetes
por: Lin, Chia-Hung, et al.
Publicado: (2015)

Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes
por: Lyu, Fu-ping, et al.
Publicado: (2020)

Continuous Subcutaneous Insulin Infusion (CSII) Combined with Oral Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomized, Controlled Trials
por: Li, Hui, et al.
Publicado: (2022)

Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy
por: Li, Feng-fei, et al.
Publicado: (2018)

CSII treatment as an option in high-risk pregnant patients with type 1 diabetes
por: Breder, Íkaro Soares Santos, et al.
Publicado: (2015)

Economic evaluation of continuous subcutaneous insulin infusion for children with diabetes - a pilot study: CSII application for children – economic evaluation
por: Petkova, Elina, et al.
Publicado: (2013)

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial
por: Haak, Thomas, et al.
Publicado: (2016)

Flash Glucose Monitoring in Subjects with Diabetes on Hemodialysis: A Pilot Study
por: Javherani, Rajesh S., et al.
Publicado: (2018)

Long-Term Effects of Initiating Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM) in People with Type 1 Diabetes and Unsatisfactory Diabetes Control
por: Senn, Jon-Duri, et al.
Publicado: (2019)

Adaptability of structured forms for CSII initiation in patients with type 2 diabetes the Getting2Goal(SM) concept
por: Cohen, O., et al.
Publicado: (2016)

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
por: King, Allen B., et al.
Publicado: (2016)

Postnatal growth of infants with neonatal diabetes: Insulin pump (CSII) versus Multiple Daily Injection (MDI) therapy
por: Alyafie, Fawzia, et al.
Publicado: (2019)

Development and validation of an instrument (CSII – Brazil) to assess users’ conceptual and procedural knowledge of continuous subcutaneous infusion systems
por: Amaral, Camilla Magalhães de Oliveira, et al.
Publicado: (2020)

NAND flash memory technologies
por: Aritome, Seiichi
Publicado: (2016)

Accuracy of flash glucose monitoring in insulin‐treated patients with type 2 diabetes
por: Sato, Tatsuya, et al.
Publicado: (2018)

Correlation Between Blood Glucose Indexes Generated by the Flash Glucose Monitoring System and Diabetic Vascular Complications
por: Sheng, Xia, et al.
Publicado: (2023)

RT‐CGM in conjunction with CSII vs MDI in optimizing glycaemic control in T1DM: Systemic review and meta‐analysis
por: William, Jimmy, et al.
Publicado: (2022)

Association of sleep quality with glycemic variability assessed by flash glucose monitoring in patients with type 2 diabetes
por: Yang, Yang, et al.
Publicado: (2021)

Liraglutide inhibits the apoptosis of human nucleus pulposus cells induced by high glucose through PI3K/Akt/caspase-3 signaling pathway
por: Ming-yan, Yao, et al.
Publicado: (2019)

Clinical Outcome and Cost-Effectiveness Analysis of CSII Versus MDI in Children and Adolescent With Type 1 Diabetes Mellitus in a Public Health Care System of China
por: Hu, Sicui, et al.
Publicado: (2021)

Experiences and decision making during paediatric transitions to continuous sub-cutaneous insulin infusion (CSII): A mixed method study
por: Altmann, Erika, et al.
Publicado: (2018)

Practical guidance for treatment of patients with diabetes using flash glucose monitoring: a pilot study
por: Koide, Keiko, et al.
Publicado: (2018)

Premature and Incomplete Overview of Health Technology Assessments for Flash Glucose Monitoring Leads to Misleading Conclusions
por: Hellmund, Richard, et al.
Publicado: (2018)

Flash glucose monitoring system in special situations
por: Rigon, Fernanda Augustini, et al.
Publicado: (2022)

Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials
por: Zhao, Xu, et al.
Publicado: (2019)

Comparison between liraglutide alone and liraglutide in combination with insulin on osteoporotic rats and their effect on bone mineral density
por: Chen, Kai, et al.
Publicado: (2021)

Real-Time Flash Glucose Monitoring Had Better Effects on Daily Glycemic Control Compared With Retrospective Flash Glucose Monitoring in Patients With Type 2 Diabetes on Premix Insulin Therapy
por: Yan, Reng-na, et al.
Publicado: (2022)

Utility of an Increment in the Basal Rate during Mealtime in Place of Pre-meal Boluses for Preschool-aged Children with Type 1 Diabetes Using CSII
por: Suzuki, Junichi, et al.
Publicado: (2009)

Differences Between Flash Glucose Monitor and Fingerprick Measurements
por: Staal, Odd Martin, et al.
Publicado: (2018)

Using Flash Continuous Glucose Monitoring in Primary Practice
por: Hirsch, Irl B., et al.
Publicado: (2019)

Using flash glucose monitoring in pregnancies in routine care of patients with gestational diabetes mellitus: a pilot study
por: Bastobbe, Sophie, et al.
Publicado: (2023)

The efficacy of liraglutide combined with intragastric balloon on weight loss
por: Yilmaz, Ahmet, et al.
Publicado: (2023)

Controlled release of liraglutide using thermogelling polymers in treatment of diabetes
por: Chen, Yipei, et al.
Publicado: (2016)

Nonvolatile memory technologies with emphasis on flash: a comprehensive guide to understanding and using flash memory devices
por: Brewer, Joe E, et al.
Publicado: (2008)

A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia
por: Reddy, M., et al.
Publicado: (2017)

Continuous subcutaneous insulin infusion and flash glucose monitoring in diabetic hemiballism-hemichorea
por: Qiang, Wei, et al.
Publicado: (2020)

An Evaluation of the Accuracy of a Flash Glucose Monitoring System in Children with Diabetes in comparison with Venous Blood Glucose
por: Cao, Bingyan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b4lh3p56ve070f9aclecpbe2kb